FCGR1A and neoplasm: While the absence of GRA4 in WT ME49 resulted in more severe pathology, the removal of GRA4 in attenuated ME49Δompdc enabled it to enhance its role in anti‐tumor immunity by boosting IFN‐I production and accumulating CD64+MAR‐1+CD11b+ DCs through our pre‐vaccination approach.